relative to the use of psychedelics for therapeutic purposes.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 8 Sponsors 1

Oct 31, 2024 · House

Interim Study Report: Recommended for Future Legislation (Vote 14-1)

Sep 20, 2024 · House

Executive Session: 10/09/2024 01:00 pm LOB 205-207

Sep 20, 2024 · House

Full Committee Work Session: 10/09/2024 09:30 am LOB 205-207

Feb 15, 2024 · House

Refer for Interim Study: MA VV 02/15/2024 HJ 5 P. 12

Feb 8, 2024 · House

Committee Report: Refer for Interim Study 02/07/2024 (Vote 20-0; CC) HC 6 P. 6

Jan 25, 2024 · House

Public Hearing: 01/31/2024 01:00 pm LOB 210-211

Jan 25, 2024 · House

Executive Session: 02/07/2024 11:00 am LOB 206-208

Dec 15, 2023 · House

Introduced 01/03/2024 and referred to Health, Human Services and Elderly Affairs HJ 1 P. 30

PASSAGE PROBABILITY

3.7% Unlikely

Why this number

Stage base In Committee — base rate 27%, measured from NH's completed sessions
Momentum -4 30/100 from the pace of recorded action
Time since last action -22 709 days quiet
Sponsor influence +3 84/100

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.